Abstract

Novel non-invasive prenatal tests using a blood sample from the mother can determine the sex and health of the growing baby from as early as 7 weeks gestation. These tests have profound implications for the choices available to women at early stages of pregnancy. These technologies are likely to be adopted on a global basis, but their implications for the developing world, particularly Asia, have been largely unexplored.

Held on International Women’s Day, this free seminar is hosted in partnership with the Humanitarian Centre as part of their Global Health Year

There will be perspectives from two expert speakers and an opportunity for questions and group discussion, to be followed by a networking drinks reception.

Speakers

The first speaker will be Alison Hall, Senior Policy Adviser at the independent health and genomics think-tank the PHG Foundation, who will outline the technologies, their potential applications and associated ethical, legal and social implications.

The second speaker will be Dr Margaret Sleeboom-Faulkner, Reader in Anthropology from the University of Sussex, who will speak on birth preferences in Asian countries.

Who should attend?

All those with an interest in biomedical innovation and translation, prenatal testing technologies and their clinical and social implications, and the impact of technological developments in low and middle income countries.

Register here

The seminar and refreshments are free, but advance registration is required to secure a place. Please note that there is no parking at Hughes Hall.